Kelonia Therapeutics to Participate in Upcoming Scientific Conferences
02 May 2024 //
BUSINESSWIRE
Kelonia to Present Preclinical Data Highlighting Therapeutic Potential
02 Apr 2024 //
BUSINESSWIRE
Kelonia Therapeutics Appoints Kristen Hege & Matha to Board of Directors
28 Mar 2024 //
BUSINESSWIRE
Astellas pursues ‘convertible’ in vivo CAR-T cell therapies with Kelonia
16 Feb 2024 //
ENDPTS
Astellas bets more than $800M on Kelonia`s delivery tech
15 Feb 2024 //
FIERCE BIOTECH
Kelonia Therapeutics Announces Upcoming Oral Presentation of Preclinical Data
02 May 2023 //
BUSINESSWIRE